+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Neuroblastoma Market and Competitive Landscape - 2020

  • ID: 5023481
  • Report
  • April 2020
  • Region: Global
  • Fore Pharma
1 of 2
The research report Global Neuroblastoma Market and Competitive Landscape - 2020, provides comprehensive insights into the Neuroblastoma pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Neuroblastoma market size and drug sales. It also provides insights into Neuroblastoma epidemiology and late stage pipeline.

This research covers the following: Neuroblastoma treatment options, Neuroblastoma late stage clinical trials pipeline, Neuroblastoma prevalence by countries, Neuroblastoma market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
  • Neuroblastoma pipeline: Find out drugs in clinical trials for the treatment of Neuroblastoma by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Neuroblastoma epidemiology: Find out the number of patients diagnosed (prevalence) with Neuroblastoma by countries
  • Neuroblastoma drugs: Identify key drugs marketed and prescribed for Neuroblastoma in the US, including trade name, molecule name, and company
  • Neuroblastoma drugs sales: Find out the sales value for Neuroblastoma drugs by countries
  • Neuroblastoma market valuations: Find out the market size for Neuroblastoma drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Neuroblastoma drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Neuroblastoma drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Neuroblastoma market
  • Develop in-depth knowledge of competition and markets
  • Analyze Neuroblastoma drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Neuroblastoma market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Neuroblastoma Treatment Options

2. Neuroblastoma Pipeline Insights
2.1. Neuroblastoma Phase 3 Clinical Trials
2.2. Neuroblastoma Phase 2 Clinical Trials
2.3. Neuroblastoma Phase 1 Clinical Trials

3. Neuroblastoma Epidemiology Analysis by Countries

4. US Neuroblastoma Market Insights
4.1. Marketed Drugs for Neuroblastoma in US
4.2. US Neuroblastoma Market Size & Forecast
4.3. US Neuroblastoma Drugs Sales & Forecast
4.4. US Neuroblastoma Market Share Analysis

5. Germany Neuroblastoma Market Insights
5.1. Marketed Drugs for Neuroblastoma in Germany
5.2. Germany Neuroblastoma Market Size & Forecast
5.3. Germany Neuroblastoma Drugs Sales Forecast
5.4. Germany Neuroblastoma Market Share Analysis

6. France Neuroblastoma Market Insights
6.1. Marketed Drugs for Neuroblastoma in France
6.2. France Neuroblastoma Market Size & Forecast
6.3. France Neuroblastoma Product Sales Forecast
6.4. France Neuroblastoma Market Share Analysis

7. Italy Neuroblastoma Market Insights
7.1. Marketed Drugs for Neuroblastoma in Italy
7.2. Italy Neuroblastoma Market Size & Forecast
7.3. Italy Neuroblastoma Product Sales Forecast
7.4. Italy Neuroblastoma Market Share Analysis

8. Spain Neuroblastoma Market Insights
8.1. Marketed Drugs for Neuroblastoma in Spain
8.2. Spain Neuroblastoma Market Size & Forecast
8.3. Spain Neuroblastoma Product Sales Forecast
8.4. Spain Neuroblastoma Market Share Analysis

9. UK Neuroblastoma Market Insights
9.1. Marketed Drugs for Neuroblastoma in UK
9.2. UK Neuroblastoma Market Size & Forecast
9.3. UK Neuroblastoma Product Sales Forecast
9.4. UK Neuroblastoma Market Share Analysis

10. Europe Neuroblastoma Market Insights
10.1. Europe Neuroblastoma Market Size & Forecast
10.2. Europe Neuroblastoma Product Sales Forecast
10.3. Europe Neuroblastoma Market Share Analysis

11. Japan Neuroblastoma Market Insights
11.1. Marketed Drugs for Neuroblastoma in Japan
11.2. Japan Neuroblastoma Market Size & Forecast
11.3. Japan Neuroblastoma Product Sales Forecast
11.4. Japan Neuroblastoma Market Share Analysis

12. Global Neuroblastoma Market Insights
12.1. Global Neuroblastoma Market Size & Forecast
12.2. Global Neuroblastoma Product Sales Forecast
12.3. Global Neuroblastoma Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Neuroblastoma Phase 3 Clinical Trials, Global, 2020
Table 2: Neuroblastoma Phase 2 Clinical Trials, Global, 2020
Table 3: Neuroblastoma Phase 1 Clinical Trials, Global, 2020
Table 4: Neuroblastoma Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Neuroblastoma in US, 2019
Table 6: US Neuroblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 7: US Neuroblastoma Product Sales ($mn), 2016 - 2024
Table 8: US Neuroblastoma Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Neuroblastoma in Germany, 2019
Table 10: Germany Neuroblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 11: Germany Neuroblastoma Product Sales ($mn), 2016 - 2024
Table 12: Germany Neuroblastoma Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Neuroblastoma in France, 2019
Table 14: France Neuroblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 15: France Neuroblastoma Product Sales ($mn), 2016 - 2024
Table 16: France Neuroblastoma Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Neuroblastoma in Italy, 2019
Table 18: Italy Neuroblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 19: Italy Neuroblastoma Product Sales ($mn), 2016 - 2024
Table 20: Italy Neuroblastoma Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Neuroblastoma in Spain, 2019
Table 22: Spain Neuroblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 23: Spain Neuroblastoma Product Sales ($mn), 2016 - 2024
Table 24: Spain Neuroblastoma Market Events and Trends, 2016 - 2024
Table 25: Marketed Drugs for Neuroblastoma in UK, 2019
Table 26: UK Neuroblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 27: UK Neuroblastoma Product Sales ($mn), 2016 - 2024
Table 28: UK Neuroblastoma Market Events and Trends, 2016 - 2024
Table 29: Europe Neuroblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 30: Europe Neuroblastoma Product Sales ($mn), 2016 - 2024
Table 31: Marketed Drugs for Neuroblastoma in Japan, 2019
Table 32: Japan Neuroblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 33: Japan Neuroblastoma Product Sales ($mn), 2016 - 2024
Table 34: Japan Neuroblastoma Market Events and Trends, 2016 - 2024
Table 35: Global Neuroblastoma Market Size & Forecast ($mn), 2016 - 2024
Table 36: Global Neuroblastoma Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Neuroblastoma Pipeline by Phase (%), Global, 2020
Figure 2: Neuroblastoma Prevalence by Countries, 2016 - 2024
Figure 3: US Neuroblastoma Market Size ($mn), 2016 - 2024
Figure 4: US Neuroblastoma Product Sales ($mn), 2016 - 2024
Figure 5: US Neuroblastoma Market Share by Drugs (%), 2019
Figure 6: US Neuroblastoma Market - Future Market Share (%), 2024
Figure 7: Germany Neuroblastoma Market Size ($mn), 2016 - 2024
Figure 8: Germany Neuroblastoma Product Sales ($mn), 2016 - 2024
Figure 9: Germany Neuroblastoma Market Share by Drugs (%), 2019
Figure 10: Germany Neuroblastoma Market - Future Market Share (%), 2024
Figure 11: France Neuroblastoma Market Size ($mn), 2016 - 2024
Figure 12: France Neuroblastoma Product Sales ($mn), 2016 - 2024
Figure 13: France Neuroblastoma Market Share by Drugs (%), 2019
Figure 14: France Neuroblastoma Market - Future Market Share (%), 2024
Figure 15: Italy Neuroblastoma Market Size ($mn), 2016 - 2024
Figure 16: Italy Neuroblastoma Product Sales ($mn), 2016 - 2024
Figure 17: Italy Neuroblastoma Market Share by Drugs (%), 2019
Figure 18: Italy Neuroblastoma Market - Future Market Share (%), 2024
Figure 19: Spain Neuroblastoma Market Size ($mn), 2016 - 2024
Figure 20: Spain Neuroblastoma Product Sales ($mn), 2016 - 2024
Figure 21: Spain Neuroblastoma Market Share by Drugs (%), 2019
Figure 22: Spain Neuroblastoma Market - Future Market Share (%), 2024
Figure 23: UK Neuroblastoma Market Size ($mn), 2016 - 2024
Figure 24: UK Neuroblastoma Product Sales ($mn), 2016 - 2024
Figure 25: UK Neuroblastoma Market Share by Drugs (%), 2019
Figure 26: UK Neuroblastoma Market - Future Market Share (%), 2024
Figure 27: Europe Neuroblastoma Market Size ($mn), 2016 - 2024
Figure 28: Europe Neuroblastoma Product Sales ($mn), 2016 - 2024
Figure 29: Europe Neuroblastoma Market Share by Drugs (%), 2019
Figure 30: Europe Neuroblastoma Market - Future Market Share (%), 2024
Figure 31: Japan Neuroblastoma Market Size ($mn), 2016 - 2024
Figure 32: Japan Neuroblastoma Product Sales ($mn), 2016 - 2024
Figure 33: Japan Neuroblastoma Market Share by Drugs (%), 2019
Figure 34: Japan Neuroblastoma Market - Future Market Share (%), 2024
Figure 35: Global Neuroblastoma Market Size ($mn), 2016 - 2024
Figure 36: Global Neuroblastoma Product Sales ($mn), 2016 - 2024
Figure 37: Global Neuroblastoma Market Share by Drugs (%), 2019
Figure 38: Global Neuroblastoma Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll